BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Fang JC, Ewald GA, Allen LA, Butler J, Westlake Canary CA, Colvin-Adams M, Dickinson MG, Levy P, Stough WG, Sweitzer NK, Teerlink JR, Whellan DJ, Albert NM, Krishnamani R, Rich MW, Walsh MN, Bonnell MR, Carson PE, Chan MC, Dries DL, Hernandez AF, Hershberger RE, Katz SD, Moore S, Rodgers JE, Rogers JG, Vest AR, Givertz MM; Heart Failure Society of America Guidelines Committee. Advanced (stage D) heart failure: a statement from the Heart Failure Society of America Guidelines Committee. J Card Fail 2015;21:519-34. [PMID: 25953697 DOI: 10.1016/j.cardfail.2015.04.013] [Cited by in Crossref: 175] [Cited by in F6Publishing: 129] [Article Influence: 25.0] [Reference Citation Analysis]
Number Citing Articles
1 Ortiz-Bautista C, Gutiérrez-Ibañes E, García-Cosío MD, Calviño-Santos R, Gómez-Bueno M, Mirabet-Pérez S, Gómez-Hospital JA, Lambert-Rodríguez JL, Garrido-Bravo IP, de la Fuente Galán L, Mombiela T, Martínez-Solano J, Martínez-Sellés M. Rationale and design of the optical coherence tomography observation of pulmonary ultra-structural changes in heart failure (OCTOPUS-CHF) study. Int J Cardiol 2020;299:296-300. [PMID: 31278027 DOI: 10.1016/j.ijcard.2019.06.063] [Reference Citation Analysis]
2 Godino C, Munafò A, Scotti A, Estévez-loureiro R, Portolés Hernández A, Arzamendi D, Fernández Peregrina E, Taramasso M, Fam NP, Ho EC, Asgar A, Vitrella G, Raineri C, Adamo M, Fiorina C, Montalto C, Fraccaro C, Giannini C, Fiorelli F, Popolo Rubbio A, Ooms J, Compagnone M, Maffeo D, Bettari L, Fürholz M, Tamburino C, Petronio AS, Grasso C, Agricola E, Van Mieghem NM, Tarantini G, Curello S, Praz F, Pascual I, Potena L, Colombo A, Maisano F, Metra M, Margonato A, Crimi G, Saia F. MitraClip in secondary mitral regurgitation as a bridge to heart transplantation: 1-year outcomes from the International MitraBridge Registry. The Journal of Heart and Lung Transplantation 2020;39:1353-62. [DOI: 10.1016/j.healun.2020.09.005] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
3 Fedson SE, Mackenzie KK, Delgado ED, Abraham MN, Estep JD, Blumenthal-barby JS, Bruce CR. Mapping the Informed Consent Process for Left Ventricular Assist Devices. ASAIO Journal 2018;64:630-5. [DOI: 10.1097/mat.0000000000000696] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
4 Shoemaker MJ, Veldman S, Van Dam A, Wainscott TL. Interpretation of Physiologic and Left Ventricular Assist Device Parameters: Implications for Physical Therapist Decision-Making. Cardiopulm Phys Ther J 2021;32:41-51. [DOI: 10.1097/cpt.0000000000000138] [Reference Citation Analysis]
5 Pinney SP, Stevenson LW. Chronic Inotropic Therapy in the Current Era: Old Wines With New Pairings. Circ Heart Fail. 2015;8:843-846. [PMID: 26374915 DOI: 10.1161/circheartfailure.115.002481] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
6 D'souza GA, Taylor MD, Banerjee RK. Methodology for Hemodynamic Assessment of a Three-Dimensional Printed Patient-Specific Vascular Test Device. Journal of Medical Devices 2019;13:031011. [DOI: 10.1115/1.4043992] [Reference Citation Analysis]
7 Vest AR, Wong WW, Chery J, Coston A, Telfer L, Lawrence M, Celkupa D, Kiernan MS, Couper G, Kawabori M, Saltzman E. Skeletal Muscle Mass Recovery Early After Left Ventricular Assist Device Implantation in Patients With Advanced Systolic Heart Failure. Circ Heart Fail 2022;15:e009012. [PMID: 35378982 DOI: 10.1161/CIRCHEARTFAILURE.121.009012] [Reference Citation Analysis]
8 Iwatsu K, Adachi T, Kamisaka K, Kamiya K, Iida Y, Yamada S; FLAGSHIP collabolators. Clinical benefit of combined assessment of physical and psychological frailty in patients with heart failure. J Am Geriatr Soc 2022. [PMID: 35352819 DOI: 10.1111/jgs.17769] [Reference Citation Analysis]
9 Mitter SS, Yancy CW. Contemporary Approaches to Patients with Heart Failure. Cardiology Clinics 2017;35:261-71. [DOI: 10.1016/j.ccl.2016.12.008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
10 Bakitas M, Dionne-Odom JN, Pamboukian SV, Tallaj J, Kvale E, Swetz KM, Frost J, Wells R, Azuero A, Keebler K, Akyar I, Ejem D, Steinhauser K, Smith T, Durant R, Kono AT. Engaging patients and families to create a feasible clinical trial integrating palliative and heart failure care: results of the ENABLE CHF-PC pilot clinical trial. BMC Palliat Care 2017;16:45. [PMID: 28859648 DOI: 10.1186/s12904-017-0226-8] [Cited by in Crossref: 25] [Cited by in F6Publishing: 21] [Article Influence: 5.0] [Reference Citation Analysis]
11 Alghamdi F, Chan M. Management of heart failure in the elderly. Curr Opin Cardiol 2017;32:217-23. [PMID: 28059840 DOI: 10.1097/HCO.0000000000000375] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Rougé A, Pelen F, Durand M, Schwebel C. Argatroban for an alternative anticoagulant in HIT during ECMO. J Intensive Care 2017;5:39. [PMID: 28680640 DOI: 10.1186/s40560-017-0235-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 3.6] [Reference Citation Analysis]
13 Qin T, Kong B, Dai C, Xiao Z, Fang J, Shuai W, Huang H. Protective effects of Dapagliflozin on the vulnerability of ventricular arrhythmia in rats with pulmonary artery hypertension induced by monocrotaline. Bioengineered 2022;13:2697-709. [DOI: 10.1080/21655979.2021.2017652] [Reference Citation Analysis]
14 Gelfman LP, Bakitas M, Warner Stevenson L, Kirkpatrick JN, Goldstein NE. The State of the Science on Integrating Palliative Care in Heart Failure. J Palliat Med 2017;20:592-603. [PMID: 29493362 DOI: 10.1089/jpm.2017.0178] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 5.8] [Reference Citation Analysis]
15 Chang YK, Kaplan H, Geng Y, Mo L, Philip J, Collins A, Allen LA, McClung JA, Denvir MA, Hui D. Referral Criteria to Palliative Care for Patients With Heart Failure: A Systematic Review. Circ Heart Fail 2020;13:e006881. [PMID: 32900233 DOI: 10.1161/CIRCHEARTFAILURE.120.006881] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
16 Luo N, Rogers JG, Dodson GC, Patel CB, Galanos AN, Milano CA, O'Connor CM, Mentz RJ. Usefulness of Palliative Care to Complement the Management of Patients on Left Ventricular Assist Devices. Am J Cardiol 2016;118:733-8. [PMID: 27474339 DOI: 10.1016/j.amjcard.2016.06.010] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
17 Habal MV, Garan AR. Long-term management of end-stage heart failure. Best Pract Res Clin Anaesthesiol 2017;31:153-66. [PMID: 29110789 DOI: 10.1016/j.bpa.2017.07.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
18 Vallabhajosyula S, Arora S, Lahewala S, Kumar V, Shantha GPS, Jentzer JC, Stulak JM, Gersh BJ, Gulati R, Rihal CS, Prasad A, Deshmukh AJ. Temporary Mechanical Circulatory Support for Refractory Cardiogenic Shock Before Left Ventricular Assist Device Surgery. J Am Heart Assoc 2018;7:e010193. [PMID: 30571481 DOI: 10.1161/JAHA.118.010193] [Cited by in Crossref: 38] [Cited by in F6Publishing: 26] [Article Influence: 12.7] [Reference Citation Analysis]
19 Kavalieratos D, Gelfman LP, Tycon LE, Riegel B, Bekelman DB, Ikejiani DZ, Goldstein N, Kimmel SE, Bakitas MA, Arnold RM. Palliative Care in Heart Failure: Rationale, Evidence, and Future Priorities. J Am Coll Cardiol 2017;70:1919-30. [PMID: 28982506 DOI: 10.1016/j.jacc.2017.08.036] [Cited by in Crossref: 106] [Cited by in F6Publishing: 81] [Article Influence: 21.2] [Reference Citation Analysis]
20 Grady PA. Advancing palliative and end-of-life science in cardiorespiratory populations: The contributions of nursing science. Heart Lung 2017;46:3-6. [PMID: 27612388 DOI: 10.1016/j.hrtlng.2016.07.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Mcdonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JG, Coats AJ, Crespo-leiro MG, Farmakis D, Gilard M, Heyman S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CS, Lyon AR, Mcmurray JJ, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GM, Ruschitzka F, Skibelund AK. Guía ESC 2021 sobre el diagnóstico y tratamiento de la insuficiencia cardiaca aguda y crónica. Revista Española de Cardiología 2022. [DOI: 10.1016/j.recesp.2021.11.027] [Reference Citation Analysis]
22 Carvalho WDN, Gonçalves KC, Miranda AL, Maria GDSA, de Fátima Silqueira SM, Moreira MDCV. Profile of Effective Donors for Heart Transplantation: Experience of a Brazilian Center. Transplantation Proceedings 2019;51:1684-8. [DOI: 10.1016/j.transproceed.2019.05.011] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
23 Fitzsimons D, Doherty LC, Murphy M, Dixon L, Donnelly P, Mcdonald K, Mcilfatrick S. Inadequate Communication Exacerbates the Support Needs of Current and Bereaved Caregivers in Advanced Heart Failure and Impedes Shared Decision-making. J Cardiovasc Nurs 2019;34:11-9. [DOI: 10.1097/jcn.0000000000000516] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 2.7] [Reference Citation Analysis]
24 Cheshire C, Bhagra CJ, Bhagra SK. A review of the management of patients with advanced heart failure in the intensive care unit. Ann Transl Med 2020;8:828. [PMID: 32793673 DOI: 10.21037/atm-20-1048] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
25 Singh GK, Ivynian SE, Davidson PM, Ferguson C, Hickman LD. Elements of Integrated Palliative Care in Chronic Heart Failure Across the Care Continuum: A Scoping Review. Heart Lung Circ 2021:S1443-9506(21)01208-7. [PMID: 34593316 DOI: 10.1016/j.hlc.2021.08.012] [Reference Citation Analysis]
26 Lee CS, Auld J. Heart Failure. Critical Care Nursing Clinics of North America 2015;27:413-25. [DOI: 10.1016/j.cnc.2015.07.009] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
27 Crespo-leiro MG, Metra M, Lund LH, Milicic D, Costanzo MR, Filippatos G, Gustafsson F, Tsui S, Barge-caballero E, De Jonge N, Frigerio M, Hamdan R, Hasin T, Hülsmann M, Nalbantgil S, Potena L, Bauersachs J, Gkouziouta A, Ruhparwar A, Ristic AD, Straburzynska-migaj E, Mcdonagh T, Seferovic P, Ruschitzka F. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology: Advanced heart failure: HFA position statement. Eur J Heart Fail 2018;20:1505-35. [DOI: 10.1002/ejhf.1236] [Cited by in Crossref: 217] [Cited by in F6Publishing: 145] [Article Influence: 54.3] [Reference Citation Analysis]
28 Barros LN, Uchoa RB, Mejia JAC, Nunes RR, Barros DASN, Rodrigues Filho F. Anesthetic protocol for right ventricular dysfunction management in heart transplantation: systematic review, development and validation. BMC Anesthesiol 2021;21:46. [PMID: 33573599 DOI: 10.1186/s12871-021-01261-5] [Reference Citation Analysis]
29 Levesque AA, Rimsans JM, Sylvester KW, Lyons EN, Frankel KA, Coakley LL, Hickey M, Montoya KA, Mehra MR, Givertz MM, Stewart GC, Connors JM. Development of an Outpatient Guideline for Optimal Anticoagulation Bridging in Patients With Durable Mechanical Circulatory Support. Crit Pathw Cardiol 2018;17:32-7. [PMID: 29432374 DOI: 10.1097/HPC.0000000000000131] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
30 Smith KR, Hsu CC, Berei TJ, Aldemerdash A, Hollis IB, Vardeny O, Rodgers JE. PARADIGM-HF Trial: Secondary Analyses Address Unanswered Questions. Pharmacotherapy 2018;38:284-98. [PMID: 29265423 DOI: 10.1002/phar.2075] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
31 Kavalieratos D, Corbelli J, Zhang D, Dionne-Odom JN, Ernecoff NC, Hanmer J, Hoydich ZP, Ikejiani DZ, Klein-Fedyshin M, Zimmermann C, Morton SC, Arnold RM, Heller L, Schenker Y. Association Between Palliative Care and Patient and Caregiver Outcomes: A Systematic Review and Meta-analysis. JAMA 2016;316:2104-14. [PMID: 27893131 DOI: 10.1001/jama.2016.16840] [Cited by in Crossref: 446] [Cited by in F6Publishing: 379] [Article Influence: 74.3] [Reference Citation Analysis]
32 Greenberg B, Fang J, Mehra M, Stevenson LW. Advanced heart failure: Trans-Atlantic perspectives on the Heart Failure Association of the European Society of Cardiology position statement: Editorial comment. Eur J Heart Fail 2018;20:1536-9. [DOI: 10.1002/ejhf.1313] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
33 Givertz MM, Defilippis EM, Landzberg MJ, Pinney SP, Woods RK, Valente AM. Advanced Heart Failure Therapies for Adults With Congenital Heart Disease. Journal of the American College of Cardiology 2019;74:2295-312. [DOI: 10.1016/j.jacc.2019.09.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
34 Oliva F, Perna E, Marini M, Nassiacos D, Cirò A, Malfatto G, Morandi F, Caico I, Perna G, Meloni S, Vincenzi A, Villani A, Vecchi AL, Minoia C, Verde A, De Maria R; RELEVANT-HF study group. Scheduled intermittent inotropes for Ambulatory Advanced Heart Failure. The RELEVANT-HF multicentre collaboration. Int J Cardiol 2018;272:255-9. [PMID: 30131229 DOI: 10.1016/j.ijcard.2018.08.048] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
35 Kitko LA, Hupcey JE, Birriel B, Alonso W. Patients' decision making process and expectations of a left ventricular assist device pre and post implantation. Heart Lung 2016;45:95-9. [PMID: 26742707 DOI: 10.1016/j.hrtlng.2015.12.003] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 3.9] [Reference Citation Analysis]
36 Iacoviello M, Vitale E, Corbo MD, Correale M, Brunetti ND. Disease-modifier Drugs in Patients with Advanced Heart Failure: How to Optimize Their Use? Heart Fail Clin 2021;17:561-73. [PMID: 34511205 DOI: 10.1016/j.hfc.2021.05.002] [Reference Citation Analysis]
37 Pacileo G, Grigioni F, Masarone D, Potena L, Bossone E. Management of Advanced Heart Failure: The Science of Uncertainty and the Art of Probability. Heart Fail Clin 2021;17:xv-xvi. [PMID: 34511217 DOI: 10.1016/j.hfc.2021.06.003] [Reference Citation Analysis]
38 Greig D, Olivares G. Inequalities in the Access to Advanced Therapy in Heart Failure. Heart Fail Clin 2015;11:523-8. [PMID: 26462092 DOI: 10.1016/j.hfc.2015.07.014] [Reference Citation Analysis]
39 Ruiz-Laiglesia FJ, Garcés-Horna V, Formiga F. Comprehensive therapeutic approach for patients with heart failure and comorbidity. Rev Clin Esp (Barc) 2016;216:323-30. [PMID: 26552747 DOI: 10.1016/j.rce.2015.09.009] [Cited by in Crossref: 5] [Article Influence: 0.7] [Reference Citation Analysis]
40 Evans RS, Kfoury AG, Horne BD, Lloyd JF, Benuzillo J, Rasmusson KD, Roberts C, Lappé DL. Clinical Decision Support to Efficiently Identify Patients Eligible for Advanced Heart Failure Therapies. Journal of Cardiac Failure 2017;23:719-26. [DOI: 10.1016/j.cardfail.2017.08.449] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 3.2] [Reference Citation Analysis]
41 Diamant MJ, Keshmiri H, Toma M. End-of-life care in patients with advanced heart failure. Curr Opin Cardiol 2020;35:156-61. [PMID: 31833961 DOI: 10.1097/HCO.0000000000000712] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
42 Zalawadiya S, Fudim M, Bhat G, Cotts W, Lindenfeld J. Extracorporeal membrane oxygenation support and post-heart transplant outcomes among United States adults. J Heart Lung Transplant 2017;36:77-81. [PMID: 27866925 DOI: 10.1016/j.healun.2016.10.008] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 4.2] [Reference Citation Analysis]
43 Liu T, Cai JP, Zhang LQ, Sun N, Cui J, Wang H, Yang JF. The mechanism of RNA oxidation involved in the development of heart failure. Free Radic Res 2019;53:910-21. [PMID: 31401895 DOI: 10.1080/10715762.2019.1646424] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
44 Samman-Tahhan A, Hedley JS, McCue AA, Bjork JB, Georgiopoulou VV, Morris AA, Butler J, Kalogeropoulos AP. INTERMACS Profiles and Outcomes Among Non-Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction. JACC Heart Fail 2018;6:743-53. [PMID: 30098970 DOI: 10.1016/j.jchf.2018.03.018] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
45 Solís García Del Pozo J, Olmeda Brull C, de Arriba Méndez JJ, Corbí Pascual M. Palliative medicine for patients with advanced heart failure: New evidence. Rev Clin Esp (Barc) 2019;219:332-41. [PMID: 30318247 DOI: 10.1016/j.rce.2018.09.003] [Reference Citation Analysis]
46 Barghash MH, Pinney SP. Contemporary Treatment of Heart Failure. Cardiac Electrophysiology Clinics 2019;11:21-37. [DOI: 10.1016/j.ccep.2018.11.005] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
47 Allen LA, Khazanie P. Behind the Scenes in “The Real World” of Heart Transplantation. Journal of the American College of Cardiology 2018;71:1726-8. [DOI: 10.1016/j.jacc.2018.02.031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Kittleson MM. Changing Role of Heart Transplantation. Heart Failure Clinics 2016;12:411-21. [DOI: 10.1016/j.hfc.2016.03.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
49 Mcgrath L, Goodlin SJ. Palliative Care in Older Adults with Cardiovascular Disease: Addressing Misconceptions to Advance Care. Curr Cardiovasc Risk Rep 2017;11. [DOI: 10.1007/s12170-017-0530-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
50 Dickinson MG, Allen LA, Albert NA, DiSalvo T, Ewald GA, Vest AR, Whellan DJ, Zile MR, Givertz MM. Remote Monitoring of Patients With Heart Failure: A White Paper From the Heart Failure Society of America Scientific Statements Committee. J Card Fail 2018;24:682-94. [PMID: 30308242 DOI: 10.1016/j.cardfail.2018.08.011] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 12.3] [Reference Citation Analysis]
51 Kiamanesh O, Kaan A, Toma M. Medical Management of Left Ventricular Assist Device Patients: A Practical Guide for the Nonexpert Clinician. Can J Cardiol 2020;36:205-15. [PMID: 31879052 DOI: 10.1016/j.cjca.2019.09.020] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
52 Lastrucci V, D'Arienzo S, Collini F, Lorini C, Zuppiroli A, Forni S, Bonaccorsi G, Gemmi F, Vannucci A. Diagnosis-related differences in the quality of end-of-life care: A comparison between cancer and non-cancer patients. PLoS One 2018;13:e0204458. [PMID: 30252912 DOI: 10.1371/journal.pone.0204458] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
53 Bouchez S, Fedele F, Giannakoulas G, Gustafsson F, Harjola VP, Karason K, Kivikko M, von Lewinski D, Oliva F, Papp Z, Parissis J, Pollesello P, Pölzl G, Tschöpe C. Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application. Cardiovasc Drugs Ther 2018;32:617-24. [PMID: 30402660 DOI: 10.1007/s10557-018-6838-2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 6.3] [Reference Citation Analysis]
54 O'Donnell AE, Schaefer KG, Stevenson LW, DeVoe K, Walsh K, Mehra MR, Desai AS. Social Worker-Aided Palliative Care Intervention in High-risk Patients With Heart Failure (SWAP-HF): A Pilot Randomized Clinical Trial. JAMA Cardiol 2018;3:516-9. [PMID: 29641819 DOI: 10.1001/jamacardio.2018.0589] [Cited by in Crossref: 38] [Cited by in F6Publishing: 31] [Article Influence: 12.7] [Reference Citation Analysis]
55 Crespo-Leiro MG, Barge-Caballero E. Advanced Heart Failure: Definition, Epidemiology, and Clinical Course. Heart Fail Clin 2021;17:533-45. [PMID: 34511203 DOI: 10.1016/j.hfc.2021.06.002] [Reference Citation Analysis]
56 Peel DS, Ko KKH, Nusem DE, Straker DK, Wrigley PC. A systematic review of psychosocial design considerations for the next generation of mechanical circulatory support. Heart Lung 2021;50:397-406. [PMID: 33621838 DOI: 10.1016/j.hrtlng.2021.01.021] [Reference Citation Analysis]
57 McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Böhm M, Burri H, Butler J, Čelutkienė J, Chioncel O, Cleland JGF, Coats AJS, Crespo-Leiro MG, Farmakis D, Gilard M, Heymans S, Hoes AW, Jaarsma T, Jankowska EA, Lainscak M, Lam CSP, Lyon AR, McMurray JJV, Mebazaa A, Mindham R, Muneretto C, Francesco Piepoli M, Price S, Rosano GMC, Ruschitzka F, Kathrine Skibelund A; Authors/Task Force Members:., ESC Scientific Document Group. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2022;24:4-131. [PMID: 35083827 DOI: 10.1002/ejhf.2333] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
58 Wever-pinzon O, Drakos SG, Mckellar SH, Horne BD, Caine WT, Kfoury AG, Li DY, Fang JC, Stehlik J, Selzman CH. Cardiac Recovery During Long-Term Left Ventricular Assist Device Support. Journal of the American College of Cardiology 2016;68:1540-53. [DOI: 10.1016/j.jacc.2016.07.743] [Cited by in Crossref: 83] [Cited by in F6Publishing: 66] [Article Influence: 13.8] [Reference Citation Analysis]
59 Kato NP, Okada I, Kagami Y, Endo M, Hatano M, Ono M, Jaarsma T, Kinugawa K. Quality of life of family caregivers of patients with a left ventricular assist device in Japan. Journal of Cardiology 2018;71:81-7. [DOI: 10.1016/j.jjcc.2017.06.004] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 2.8] [Reference Citation Analysis]
60 Ruiz-laiglesia F, Garcés-horna V, Formiga F. Comprehensive therapeutic approach for patients with heart failure and comorbidity. Revista Clínica Española (English Edition) 2016;216:323-30. [DOI: 10.1016/j.rceng.2015.09.008] [Reference Citation Analysis]
61 Rao VK, Tsai A. Management of Patients on Mechanical Circulatory Assist Devices During Noncardiac Surgery. Int Anesthesiol Clin 2018;56:e1-e27. [PMID: 30204602 DOI: 10.1097/AIA.0000000000000205] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
62 Piamjariyakul U, Petitte T, Smothers A, Wen S, Morrissey E, Young S, Sokos G, Moss AH, Smith CE. Study protocol of coaching end-of-life palliative care for advanced heart failure patients and their family caregivers in rural appalachia: a randomized controlled trial. BMC Palliat Care 2019;18:119. [PMID: 31884945 DOI: 10.1186/s12904-019-0500-z] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 1.7] [Reference Citation Analysis]
63 Fernández-Martinez J, Romero-Correa M, Salamanca-Bautista P, Aramburu-Bodas Ó, Formiga F, Vázquez-Rodríguez P, Conde-Martel A, García-García JA, Páez-Rubio I, López-Reboiro M, Sánchez-Sánchez C, Arias-Jiménez JL; EPICTER Investigators group. Prevalence of advanced heart failure and use of palliative care in admitted patients: Findings from the EPICTER study. Int J Cardiol 2021;327:125-31. [PMID: 33171167 DOI: 10.1016/j.ijcard.2020.11.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
64 Al-kindi SG, Al-suwaidi J, Jayyousi A, Oliveira GH, Abi Khalil C. Impact of Diabetes Mellitus on Survival in Patients Bridged to Transplantation with Left Ventricular Assist Devices in the United States. ASAIO Journal 2019;65:587-92. [DOI: 10.1097/mat.0000000000000896] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
65 Ufere NN, Donlan J, Waldman L, Patel A, Dienstag JL, Friedman LS, Corey KE, Hashemi N, Carolan P, Mullen AC, Thiim M, Bhan I, Nipp R, Greer J, Temel J, Chung RT, El-Jawahri A. Physicians' Perspectives on Palliative Care for Patients With End-Stage Liver Disease: A National Survey Study. Liver Transpl 2019;25:859-69. [PMID: 30963669 DOI: 10.1002/lt.25469] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 7.0] [Reference Citation Analysis]
66 Davis MR, Lee CS, Corcoran A, Gupta N, Uchmanowicz I, Denfeld QE. Gender differences in the prevalence of frailty in heart failure: A systematic review and meta-analysis. Int J Cardiol 2021;333:133-40. [PMID: 33657397 DOI: 10.1016/j.ijcard.2021.02.062] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
67 Dharmarajan K, Foster J, Coylewright M, Green P, Vavalle JP, Faheem O, Huang PH, Krishnaswamy A, Thourani VH, McCoy LA, Wang TY. The medically managed patient with severe symptomatic aortic stenosis in the TAVR era: Patient characteristics, reasons for medical management, and quality of shared decision making at heart valve treatment centers. PLoS One 2017;12:e0175926. [PMID: 28430791 DOI: 10.1371/journal.pone.0175926] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
68 Yancy CW, Januzzi JL, Allen LA, Butler J, Davis LL, Fonarow GC, Ibrahim NE, Jessup M, Lindenfeld J, Maddox TM, Masoudi FA, Motiwala SR, Patterson JH, Walsh MN, Wasserman A. 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction. Journal of the American College of Cardiology 2018;71:201-30. [DOI: 10.1016/j.jacc.2017.11.025] [Cited by in Crossref: 161] [Cited by in F6Publishing: 122] [Article Influence: 40.3] [Reference Citation Analysis]
69 Chinyere IR, Balakrishnan M, Hutchinson MD. The emerging role of cardiac contractility modulation in heart failure treatment. Curr Opin Cardiol 2022;37:30-5. [PMID: 34698667 DOI: 10.1097/HCO.0000000000000929] [Reference Citation Analysis]
70 Yin MY, Strege J, Gilbert EM, Stehlik J, McKellar SH, Elmer A, Anderson T, Aljuaid M, Nativi-Nicolau J, Koliopoulou AG, Davis E, Fang JC, Drakos SG, Selzman CH, Wever-Pinzon O. Impact of Shared Care in Remote Areas for Patients With Left Ventricular Assist Devices. JACC Heart Fail 2020;8:302-12. [PMID: 32241537 DOI: 10.1016/j.jchf.2020.01.004] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
71 Santangeli P, Rame JE, Birati EY, Marchlinski FE. Management of Ventricular Arrhythmias in Patients With Advanced Heart Failure. Journal of the American College of Cardiology 2017;69:1842-60. [DOI: 10.1016/j.jacc.2017.01.047] [Cited by in Crossref: 52] [Cited by in F6Publishing: 37] [Article Influence: 10.4] [Reference Citation Analysis]
72 Keteyian SJ, Kerrigan DJ. Tugging on a Simpler Test to Evaluate Physical Mobility and Function in Patients With Heart Failure. J Card Fail 2016;22:651-2. [PMID: 26777756 DOI: 10.1016/j.cardfail.2016.01.002] [Reference Citation Analysis]
73 Kitko L, Mcilvennan CK, Bidwell JT, Dionne-odom JN, Dunlay SM, Lewis LM, Meadows G, Sattler EL, Schulz R, Strömberg A; On behalf of the American Heart Association Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; Council on Clinical Cardiology; and Council on Lifestyle and Cardiometabolic Health. Family Caregiving for Individuals With Heart Failure: A Scientific Statement From the American Heart Association. Circulation 2020;141. [DOI: 10.1161/cir.0000000000000768] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 7.5] [Reference Citation Analysis]
74 Bekfani T, Westphal F, Schulze PC. Therapeutic options in advanced heart failure. Clin Res Cardiol 2018;107:114-9. [PMID: 29987596 DOI: 10.1007/s00392-018-1318-z] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
75 Lombardi CM, Cimino G, Pellicori P, Bonelli A, Inciardi RM, Pagnesi M, Tomasoni D, Ravera A, Adamo M, Carubelli V, Metra M. Congestion in Patients with Advanced Heart Failure: Assessment and Treatment. Heart Fail Clin 2021;17:575-86. [PMID: 34511206 DOI: 10.1016/j.hfc.2021.05.003] [Reference Citation Analysis]
76 Glynn J, Song H, Hull B, Withers S, Gelow J, Mudd J, Starr A, Wampler R. The OregonHeart Total Artificial Heart: Design and Performance on a Mock Circulatory Loop: OREGONHEART TOTAL ARTIFICIAL HEART. Artificial Organs 2017;41:904-10. [DOI: 10.1111/aor.12959] [Cited by in Crossref: 16] [Cited by in F6Publishing: 10] [Article Influence: 3.2] [Reference Citation Analysis]
77 Arora S, Atreya AR, Birati EY, Shore S. Temporary Mechanical Circulatory Support as a Bridge to Heart Transplant or Durable Left Ventricular Assist Device. Interv Cardiol Clin 2021;10:235-49. [PMID: 33745672 DOI: 10.1016/j.iccl.2020.12.011] [Reference Citation Analysis]
78 Lewin WH, Schaefer KG. Integrating palliative care into routine care of patients with heart failure: models for clinical collaboration. Heart Fail Rev 2017;22:517-24. [PMID: 28191605 DOI: 10.1007/s10741-017-9599-2] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]
79 Zhang D, Tu H, Wadman MC, Li YL. Substrates and potential therapeutics of ventricular arrhythmias in heart failure. Eur J Pharmacol 2018;833:349-56. [PMID: 29940156 DOI: 10.1016/j.ejphar.2018.06.024] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
80 Chaudhry SP, Stewart GC. Advanced Heart Failure: Prevalence, Natural History, and Prognosis. Heart Fail Clin 2016;12:323-33. [PMID: 27371510 DOI: 10.1016/j.hfc.2016.03.001] [Cited by in Crossref: 44] [Cited by in F6Publishing: 33] [Article Influence: 8.8] [Reference Citation Analysis]
81 Finn L, Malhotra S. The Development of Pathways in Palliative Medicine: Definition, Models, Cost and Quality Impact. Healthcare (Basel) 2019;7:E22. [PMID: 30717281 DOI: 10.3390/healthcare7010022] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
82 George S, Leasure AR, McGovern A, Horstmanshof DA. Reduction of Postoperative Infections Through Routine Preoperative Universal Decolonization of Advanced Heart Failure Patients With Chlorhexidine and Mupirocin Before Left Ventricular Assist Device Implantation: A Single-Center Observational Study. Dimens Crit Care Nurs 2020;39:312-20. [PMID: 33009271 DOI: 10.1097/DCC.0000000000000443] [Reference Citation Analysis]
83 Heidenreich PA, Bozkurt B, Aguilar D, Allen LA, Byun J, Colvin MM, Deswal A, Drazner MH, Dunlay SM, Evers LR, Fang JC, Fedson SE, Fonarow GC, Hayek SS, Hernandez AF, Khazanie P, Kittleson MM, Lee CS, Link MS, Milano CA, Nnacheta LC, Sandhu AT, Stevenson LW, Vardeny O, Vest AR, Yancy CW. 2022 American College of Cardiology/American Heart Association/Heart Failure Society of America Guideline for the Management of Heart Failure: Executive Summary. Journal of Cardiac Failure 2022. [DOI: 10.1016/j.cardfail.2022.02.009] [Reference Citation Analysis]
84 Grady KL, Allen LA, Goetz PW. Psychosocial Considerations of Mechanical Circulatory Support: Decision Making, Behavioral Evaluation, Quality of Life, Caregivers, and End of Life. In: Montalto A, Loforte A, Musumeci F, Krabatsch T, Slaughter MS, editors. Mechanical Circulatory Support in End-Stage Heart Failure. Cham: Springer International Publishing; 2017. pp. 467-76. [DOI: 10.1007/978-3-319-43383-7_45] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
85 Ades PA, Keteyian SJ, Wright JS, Hamm LF, Lui K, Newlin K, Shepard DS, Thomas RJ. Increasing Cardiac Rehabilitation Participation From 20% to 70%: A Road Map From the Million Hearts Cardiac Rehabilitation Collaborative. Mayo Clin Proc. 2017;92:234-242. [PMID: 27855953 DOI: 10.1016/j.mayocp.2016.10.014] [Cited by in Crossref: 141] [Cited by in F6Publishing: 129] [Article Influence: 23.5] [Reference Citation Analysis]
86 Polaska P, Jerzak-Wodzynska G, Smigielski W, Gajda J, Rozentryt P, Korewicki J, Sobieszczanska-Malek M, Zielinski T, Rywik TM. Long term outcome of heart failure patients disqualified from heart transplantation. Acta Cardiol 2021;76:525-33. [PMID: 33432873 DOI: 10.1080/00015385.2020.1852755] [Reference Citation Analysis]
87 Fadol AP, Patel A, Shelton V, Krause KJ, Bruera E, Palaskas NL. Palliative care referral criteria and outcomes in cancer and heart failure: a systematic review of literature. Cardiooncology 2021;7:32. [PMID: 34556191 DOI: 10.1186/s40959-021-00117-8] [Reference Citation Analysis]
88 Trenta AM, Luciani M, Moro M, Patella S, Di Mauro S, Vellone E, Ausili D. Self-care in Adults With a Retro-auricular Left Ventricular Assist Device: An Interpretive Description. Clin Nurs Res 2021;:10547738211063538. [PMID: 34886692 DOI: 10.1177/10547738211063538] [Reference Citation Analysis]
89 Rossini R, Valente S, Colivicchi F, Baldi C, Caldarola P, Chiappetta D, Cipriani M, Ferlini M, Gasparetto N, Gilardi R, Giubilato S, Imazio M, Marini M, Roncon L, Scotto di Uccio F, Somaschini A, Sorini Dini C, Trambaiolo P, Usmiani T, Gulizia MM, Gabrielli D. ANMCO POSITION PAPER: Role of intra-aortic balloon pump in patients with acute advanced heart failure and cardiogenic shock. Eur Heart J Suppl 2021;23:C204-20. [PMID: 34456647 DOI: 10.1093/eurheartj/suab074] [Reference Citation Analysis]
90 Kuehneman T, Gregory M, de Waal D, Davidson P, Frickel R, King C, Gradwell E, Handu D. Academy of Nutrition and Dietetics Evidence-Based Practice Guideline for the Management of Heart Failure in Adults. J Acad Nutr Diet 2018;118:2331-45. [PMID: 29759644 DOI: 10.1016/j.jand.2018.03.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
91 Beaumier A, Rush JE, Yang VK, Freeman LM. Clinical findings and survival time in dogs with advanced heart failure. J Vet Intern Med 2018;32:944-50. [PMID: 29635788 DOI: 10.1111/jvim.15126] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
92 Braun LT, Grady KL, Kutner JS, Adler E, Berlinger N, Boss R, Butler J, Enguidanos S, Friebert S, Gardner TJ, Higgins P, Holloway R, Konig M, Meier D, Morrissey MB, Quest TE, Wiegand DL, Coombs-lee B, Fitchett G, Gupta C, Roach WH. Palliative Care and Cardiovascular Disease and Stroke: A Policy Statement From the American Heart Association/American Stroke Association. Circulation 2016;134. [DOI: 10.1161/cir.0000000000000438] [Cited by in Crossref: 103] [Cited by in F6Publishing: 46] [Article Influence: 17.2] [Reference Citation Analysis]
93 Ben Avraham B, Crespo-Leiro MG, Filippatos G, Gotsman I, Seferovic P, Hasin T, Potena L, Milicic D, Coats AJS, Rosano G, Ruschitzka F, Metra M, Anker S, Altenberger J, Adamopoulos S, Barac YD, Chioncel O, De Jonge N, Elliston J, Frigeiro M, Goncalvesova E, Grupper A, Hamdan R, Hammer Y, Hill L, Itzhaki Ben Zadok O, Abuhazira M, Lavee J, Mullens W, Nalbantgil S, Piepoli MF, Ponikowski P, Ristic A, Ruhparwar A, Shaul A, Tops LF, Tsui S, Winnik S, Jaarsma T, Gustafsson F, Ben Gal T. HFA of the ESC Position paper on the management of LVAD supported patients for the non LVAD specialist healthcare provider Part 1: Introduction and at the non-hospital settings in the community. ESC Heart Fail 2021. [PMID: 34519177 DOI: 10.1002/ehf2.13588] [Reference Citation Analysis]
94 Denfeld QE, Winters-Stone K, Mudd JO, Hiatt SO, Chien CV, Lee CS. Frequency of and Significance of Physical Frailty in Patients With Heart Failure. Am J Cardiol 2017;119:1243-9. [PMID: 28209349 DOI: 10.1016/j.amjcard.2016.12.024] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.4] [Reference Citation Analysis]
95 Cascino TM, Aaronson KD, Stewart GC. Identifying Stage D Heart Failure: Data From the Most Recent Registries. Curr Heart Fail Rep 2019;16:130-9. [PMID: 31250278 DOI: 10.1007/s11897-019-00433-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
96 Chih S, McDonald M, Dipchand A, Kim D, Ducharme A, Kaan A, Abbey S, Toma M, Anderson K, Davey R, Mielniczuk L, Campbell P, Zieroth S, Bourgault C, Badiwala M, Clarke B, Belanger E, Carrier M, Conway J, Doucette K, Giannetti N, Isaac D, MacArthur R, Senechal M. Canadian Cardiovascular Society/Canadian Cardiac Transplant Network Position Statement on Heart Transplantation: Patient Eligibility, Selection, and Post-Transplantation Care. Can J Cardiol 2020;36:335-56. [PMID: 32145863 DOI: 10.1016/j.cjca.2019.12.025] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
97 Pendyal A, Gelow JM. Cardiohepatic Interactions. Heart Failure Clinics 2016;12:349-61. [DOI: 10.1016/j.hfc.2016.03.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
98 Teramatsu H, Shiraishi J, Matsushima Y, Araki M, Okazaki T, Saeki S. Using Physical Function to Predict Hospital Readmission within 1 Year in Patients with Heart Failure. Prog Rehabil Med 2019;4:20190018. [PMID: 32789265 DOI: 10.2490/prm.20190018] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
99 Ginwalla M. Home Inotropes and Other Palliative Care. Heart Failure Clinics 2016;12:437-48. [DOI: 10.1016/j.hfc.2016.03.005] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
100 Gentile P, Marini C, Ammirati E, Perna E, Saponara G, Garascia A, D'Angelo L, Verde A, Foti G, Masciocco G, Frigerio M, Cipriani M. Long-term administration of intravenous inotropes in advanced heart failure. ESC Heart Fail 2021. [PMID: 34191408 DOI: 10.1002/ehf2.13394] [Reference Citation Analysis]
101 Jobbé-Duval A, Bochaton T, Baudry G, Bonnefoy-Cudraz E, Hugon-Vallet E, Pozzi M, Obadia JF, Tomasevic D, Amaz C, Mewton N, Sebbag L. Outcome Predictors and Safety of Home Dobutamine Intravenous Infusion in End Stage Heart Failure Patients. J Clin Med 2021;10:2571. [PMID: 34200733 DOI: 10.3390/jcm10122571] [Reference Citation Analysis]
102 Cesini S, Bhagra S, Pettit SJ. Low Pulmonary Artery Pulsatility Index Is Associated With Adverse Outcomes in Ambulatory Patients With Advanced Heart Failure. J Card Fail 2020;26:352-9. [PMID: 31981694 DOI: 10.1016/j.cardfail.2020.01.014] [Cited by in Crossref: 3] [Article Influence: 1.5] [Reference Citation Analysis]
103 Okumura T, Sawamura A, Murohara T. Palliative and end-of-life care for heart failure patients in an aging society. Korean J Intern Med 2018;33:1039-49. [PMID: 29779361 DOI: 10.3904/kjim.2018.106] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
104 Puckett C, Mudd JO. Tailoring Therapies in Advanced Heart Failure. Heart Failure Clinics 2016;12:375-84. [DOI: 10.1016/j.hfc.2016.03.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
105 Jurney PL, Glynn JJ, Dykan IV, Hagen MW, Kaul S, Wampler RK, Hinds MT, Giraud GD. Characterization of a pulsatile rotary total artificial heart. Artif Organs 2021;45:135-42. [PMID: 32857895 DOI: 10.1111/aor.13810] [Reference Citation Analysis]
106 Solís García del Pozo J, Olmeda Brull C, de Arriba Méndez J, Corbí Pascual M. Palliative medicine for patients with advanced heart failure: New evidence. Revista Clínica Española (English Edition) 2019;219:332-41. [DOI: 10.1016/j.rceng.2018.09.010] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
107 Knoepke CE, Chaussee EL, Matlock DD, Thompson JS, McIlvennan CK, Ambardekar AV, Schaffer EM, Khazanie P, Scherer L, Arnold RM, Allen LA. Changes over Time in Patient Stated Values and Treatment Preferences Regarding Aggressive Therapies: Insights from the DECIDE-LVAD Trial. Med Decis Making 2021;:272989X211028234. [PMID: 34296623 DOI: 10.1177/0272989X211028234] [Reference Citation Analysis]
108 Mann DL, Greene SJ, Givertz MM, Vader JM, Starling RC, Ambrosy AP, Shah P, McNulty SE, Mahr C, Gupta D, Redfield MM, Lala A, Lewis GD, Mohammed SF, Gilotra NA, DeVore AD, Gorodeski EZ, Desvigne-Nickens P, Hernandez AF, Braunwald E; LIFE Investigators. Sacubitril/Valsartan in Advanced Heart Failure With Reduced Ejection Fraction: Rationale and Design of the LIFE Trial. JACC Heart Fail 2020;8:789-99. [PMID: 32641226 DOI: 10.1016/j.jchf.2020.05.005] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
109 Denfeld QE, Winters-Stone K, Mudd JO, Gelow JM, Kurdi S, Lee CS. The prevalence of frailty in heart failure: A systematic review and meta-analysis. Int J Cardiol 2017;236:283-9. [PMID: 28215466 DOI: 10.1016/j.ijcard.2017.01.153] [Cited by in Crossref: 112] [Cited by in F6Publishing: 94] [Article Influence: 22.4] [Reference Citation Analysis]
110 Gustafsson F, Ben Avraham B, Chioncel O, Hasin T, Grupper A, Shaul A, Nalbantgil S, Hammer Y, Mullens W, Tops LF, Elliston J, Tsui S, Milicic D, Altenberger J, Abuhazira M, Winnik S, Lavee J, Piepoli MF, Hill L, Hamdan R, Ruhparwar A, Anker S, Crespo-Leiro MG, Coats AJS, Filippatos G, Metra M, Rosano G, Seferovic P, Ruschitzka F, Adamopoulos S, Barac Y, De Jonge N, Frigerio M, Goncalvesova E, Gotsman I, Itzhaki Ben Zadok O, Ponikowski P, Potena L, Ristic A, Jaarsma T, Ben Gal T. HFA of the ESC position paper on the management of LVAD-supported patients for the non-LVAD specialist healthcare provider Part 3: at the hospital and discharge. ESC Heart Fail 2021. [PMID: 34585525 DOI: 10.1002/ehf2.13590] [Reference Citation Analysis]
111 Mcdonagh J, Ferguson C, Newton PJ. Frailty Assessment in Heart Failure: an Overview of the Multi-domain Approach. Curr Heart Fail Rep 2018;15:17-23. [DOI: 10.1007/s11897-018-0373-0] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
112 Hedley JS, Samman-Tahhan A, McCue AA, Bjork JB, Butler J, Georgiopoulou VV, Morris AA, Kalogeropoulos AP. Definitions of Stage D heart failure and outcomes among outpatients with heart failure and reduced ejection fraction. Int J Cardiol 2018;272:250-4. [PMID: 30122504 DOI: 10.1016/j.ijcard.2018.08.046] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
113 Maddox TM, Januzzi JL, Allen LA, Breathett K, Butler J, Davis LL, Fonarow GC, Ibrahim NE, Lindenfeld J, Masoudi FA, Motiwala SR, Oliveros E, Patterson JH, Walsh MN, Wasserman A, Yancy CW, Youmans QR. 2021 Update to the 2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart Failure With Reduced Ejection Fraction. Journal of the American College of Cardiology 2021;77:772-810. [DOI: 10.1016/j.jacc.2020.11.022] [Cited by in Crossref: 53] [Cited by in F6Publishing: 52] [Article Influence: 53.0] [Reference Citation Analysis]
114 Herr JJ, Ravichandran A, Sheikh FH, Lala A, Chien CV, Hsiao S, Srivastava A, Pedrotty D, Nowaczyk J, Tompkins S, Ahmed S, Xiang F, Forest S, Tong MZ, D'souza B; IDEAL-HF investigators. Practices of Referring Patients to Advanced Heart Failure Centers. J Card Fail 2021:S1071-9164(21)00217-7. [PMID: 34146684 DOI: 10.1016/j.cardfail.2021.05.024] [Reference Citation Analysis]
115 Cousino MK, Yu S, Blume ED, Henderson HT, Hollander SA, Khan S, Parent JJ, Schumacher KR. Circumstances surrounding end-of-life in pediatric patients pre- and post-heart transplant: a report from the Pediatric Heart Transplant Society. Pediatr Transplant 2021;:e14196. [PMID: 34820983 DOI: 10.1111/petr.14196] [Reference Citation Analysis]
116 Wells R, Stockdill ML, Dionne-Odom JN, Ejem D, Burgio KL, Durant RW, Engler S, Azuero A, Pamboukian SV, Tallaj J, Swetz KM, Kvale E, Tucker RO, Bakitas M. Educate, Nurture, Advise, Before Life Ends Comprehensive Heartcare for Patients and Caregivers (ENABLE CHF-PC): study protocol for a randomized controlled trial. Trials 2018;19:422. [PMID: 30081933 DOI: 10.1186/s13063-018-2770-9] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
117 Chuzi S, Allen LA, Dunlay SM, Warraich HJ. Palliative Inotrope Therapy: A Narrative Review. JAMA Cardiol 2019;4:815. [DOI: 10.1001/jamacardio.2019.2081] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
118 Brawner CA, Ehrman JK, Shafiq A, Saval MA, Russell SD, Lanfear DE, Keteyian SJ. Challenges with Percent Predicted Maximal V˙O2 in Patients with Heart Failure. Medicine & Science in Sports & Exercise 2018;50:204-10. [DOI: 10.1249/mss.0000000000001431] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
119 Nakazawa M, Suzuki T, Shiga T, Suzuki A, Hagiwara N. Deactivation of implantable cardioverter defibrillator in Japanese patients with end-stage heart failure. J Arrhythm 2021;37:196-202. [PMID: 33664903 DOI: 10.1002/joa3.12465] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
120 Kalmanovich E, Audurier Y, Akodad M, Mourad M, Battistella P, Agullo A, Gaudard P, Colson P, Rouviere P, Albat B, Ricci JE, Roubille F. Management of advanced heart failure: a review. Expert Rev Cardiovasc Ther 2018;16:775-94. [PMID: 30282492 DOI: 10.1080/14779072.2018.1530112] [Cited by in Crossref: 2] [Article Influence: 0.5] [Reference Citation Analysis]
121 Gelfman LP, Kavalieratos D, Teuteberg WG, Lala A, Goldstein NE. Primary palliative care for heart failure: what is it? How do we implement it? Heart Fail Rev 2017;22:611-20. [PMID: 28281018 DOI: 10.1007/s10741-017-9604-9] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 6.0] [Reference Citation Analysis]
122 Tobin RS, Samsky MD, Kuchibhatla M, O'Connor CM, Fiuzat M, Warraich HJ, Anstrom KJ, Granger BB, Mark DB, Tulsky JA, Rogers JG, Mentz RJ, Johnson KS. Race Differences in Quality of Life following a Palliative Care Intervention in Patients with Advanced Heart Failure: Insights from the Palliative Care in Heart Failure Trial. J Palliat Med 2021. [PMID: 34851740 DOI: 10.1089/jpm.2021.0220] [Reference Citation Analysis]
123 Loupy A, Coutance G, Bonnet G, Van Keer J, Raynaud M, Aubert O, Bories MC, Racapé M, Yoo D, Duong Van Huyen JP, Bruneval P, Taupin JL, Lefaucheur C, Varnous S, Leprince P, Guillemain R, Empana JP, Levine R, Naesens M, Patel JK, Jouven X, Kobashigawa J. Identification and Characterization of Trajectories of Cardiac Allograft Vasculopathy After Heart Transplantation: A Population-Based Study. Circulation 2020;141:1954-67. [PMID: 32363949 DOI: 10.1161/CIRCULATIONAHA.119.044924] [Cited by in Crossref: 13] [Cited by in F6Publishing: 2] [Article Influence: 6.5] [Reference Citation Analysis]
124 Kaufman BD, Cohen HJ. Palliative care in pediatric heart failure and transplantation. Curr Opin Pediatr 2019;31:611-6. [PMID: 31335747 DOI: 10.1097/MOP.0000000000000799] [Cited by in Crossref: 7] [Cited by in F6Publishing: 1] [Article Influence: 3.5] [Reference Citation Analysis]
125 Shreibati JB, Sheng S, Fonarow GC, Devore AD, Yancy CW, Bhatt DL, Schulte P, Peterson ED, Hernandez A, Heidenreich PA. Heart failure medications prescribed at discharge for patients with left ventricular assist devices. American Heart Journal 2016;179:99-106. [DOI: 10.1016/j.ahj.2016.06.011] [Cited by in Crossref: 8] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
126 Gok Metin Z, Ejem D, Dionne-Odom JN, Turkman Y, Salvador C, Pamboukian S, Bakitas M. Mind-Body Interventions for Individuals With Heart Failure: A Systematic Review of Randomized Trials. J Card Fail. 2018;24:186-201. [PMID: 28939458 DOI: 10.1016/j.cardfail.2017.09.008] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.6] [Reference Citation Analysis]
127 Bellino MC, Massari F, Albanese M, Ursi R, Angelini G, Lisi F, Amato L, Scicchitano P, Guida P, Brunetti ND, Di Serio F, Ciccone MM, Iacoviello M. Baseline and incident hypochloremia in chronic heart failure outpatients: Clinical correlates and prognostic role. Eur J Intern Med 2021;84:32-7. [PMID: 32896445 DOI: 10.1016/j.ejim.2020.08.021] [Reference Citation Analysis]
128 Dunlay SM, Roger VL, Killian JM, Weston SA, Schulte PJ, Subramaniam AV, Blecker SB, Redfield MM. Advanced Heart Failure Epidemiology and Outcomes: A Population-Based Study. JACC Heart Fail 2021:S2213-1779(21)00234-1. [PMID: 34391736 DOI: 10.1016/j.jchf.2021.05.009] [Reference Citation Analysis]
129 Stewart GC, Ambardekar AV, Kittleson MM. Defining Ambulatory Advanced Heart Failure: MedaMACS and Beyond. Curr Heart Fail Rep 2017;14:498-506. [PMID: 28952014 DOI: 10.1007/s11897-017-0363-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
130 Yu H, Del Nido PJ, Geva T, Yang C, Wu Z, Rathod RH, Huang X, Billiar KL, Tang D. Multi-Band Surgery for Repaired Tetralogy of Fallot Patients With Reduced Right Ventricle Ejection Fraction: A Pilot Study. Front Physiol 2020;11:198. [PMID: 32265727 DOI: 10.3389/fphys.2020.00198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
131 Felker GM, Solomon SD, Claggett B, Diaz R, McMurray JJV, Metra M, Anand I, Crespo-Leiro MG, Dahlström U, Goncalvesova E, Howlett JG, MacDonald P, Parkhomenko A, Tomcsányi J, Abbasi SA, Heitner SB, Hucko T, Kupfer S, Malik FI, Teerlink JR. Assessment of Omecamtiv Mecarbil for the Treatment of Patients With Severe Heart Failure: A Post Hoc Analysis of Data From the GALACTIC-HF Randomized Clinical Trial. JAMA Cardiol 2021. [PMID: 34643642 DOI: 10.1001/jamacardio.2021.4027] [Reference Citation Analysis]
132 Ebong I, Mazimba S, Breathett K. Cardiac Biomarkers in Advanced Heart Failure: How Can They Impact Our Pre-transplant or Pre-LVAD Decision-making. Curr Heart Fail Rep 2019;16:274-84. [PMID: 31741231 DOI: 10.1007/s11897-019-00447-w] [Cited by in Crossref: 2] [Article Influence: 0.7] [Reference Citation Analysis]
133 Riggs JR, Reyentovich A, Maurer MS, Dodson JA. Frailty and Advanced Heart Failure in Older Adults. Curr Cardiovasc Risk Rep 2017;11. [DOI: 10.1007/s12170-017-0539-4] [Cited by in Crossref: 3] [Article Influence: 0.6] [Reference Citation Analysis]
134 Rao A, Anderson KM, Mohammed S, Hofmeyer M, Gholami SS, Sheikh FH, Rodrigo ME, Crowell NA, Javed H, Gupta S, Hajouli S, Stewart DE, Hamad A, Najjar SS, Groninger H. Chronic Intravenous Inotropic Support as Palliative Therapy and Bridge Therapy for Patients With Advanced Heart Failure: A Single-Center Experience. J Card Fail 2021:S1071-9164(21)00242-6. [PMID: 34153459 DOI: 10.1016/j.cardfail.2021.06.006] [Reference Citation Analysis]
135 Miller LW, Rogers JG. Evolution of Left Ventricular Assist Device Therapy for Advanced Heart Failure: A Review. JAMA Cardiol 2018;3:650. [DOI: 10.1001/jamacardio.2018.0522] [Cited by in Crossref: 36] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]